(26 February 2024, Singapore) Templewater, a leading private equity firm specializing in mid-market control buyout opportunities in Asia Pacific, is pleased to announce that its portfolio company, OncoCare Medical (“OncoCare”), has entered into a Letter of Intent (LOI) with Thomson Hospitals Sdn. Bhd. (“THSB”) for exclusive negotiations regarding the provision of oncology services in Kuala Lumpur, Malaysia.
The establishment of OncoCare Malaysia represents a significant step in OncoCare’s regional expansion strategy, building on its established presence in Singapore. By partnering with THSB, OncoCare is poised to deliver its reputable oncology services to a broader patient base in Malaysia, further cementing its status as a leading provider of cancer care in Southeast Asia.
THSB, a subsidiary and flagship hospital of TMC Life Sciences Berhad, which is listed on the Main Market of Bursa Malaysia Securities Berhad, has been at the forefront of providing exceptional medical care since 2008.
Templewater is proud to support OncoCare's vision as it embarks on this new chapter, enhancing the scope and impact of its oncology services beyond Singapore's borders.
FOR FURTHER INFORMATION, PLEASE CONTACT:
Templewater
Jason Li
Investor Relations
ir@templewater.com
+852 3187 5000
About Templewater Group
Founded in 2018, the Templewater Group (“Templewater”) is an alternative asset management firm headquartered in Hong Kong. Templewater provides investment solutions to institutions, entrepreneurs, and family offices across various asset classes including private equity, impact investing, and real estate.
Templewater’s private equity strategy focuses on mid-market control buyout opportunities in the Asia Pacific. With global direct investments and buyout experience across sectors, Templewater actively partners with management teams to implement value creation tools and best practices, helping portfolio companies achieve their full potential. The firm currently manages capital on behalf of leading institutional investors.
To learn more about Templewater, please visit www.templewater.com
About OncoCare
Founded in 2007 in Singapore, OncoCare is one of the largest private medical oncology specialist centers providing a one-stop multi-disciplinary services, including diagnosis, cancer treatment, palliative treatment and other professional medical services.
To learn more about OncoCare, please visit www.oncocare.sg
About THSB
Established in 2008, THSB is the shareholding entity of Thomson Hospital Kota Damansara ("THKD"), the flagship hospital of TMC Life Sciences Berhad with a wide array of specialties. Located in Kota Damansara, THKD is well-linked to Kuala Lumpur via road and the mass rapid transit (MRT) system. With 554 beds, THKD offers comprehensive medical care to the highest international standards through world-class facilities and is fully equipped with innovative technology and excellent customer services.
To learn more about THKD, please visit www.thomsonhospitals.com
